At a glance

CDC supports Wyoming and other state and local health departments, or their bona fide agents, through cooperative agreements to support childhood lead poisoning prevention activities. Read about the program's successes.

Decorative roadside sign states welcome to Wyoming

About the Program

The State of Wyoming received $465,000 through cooperative agreement EH21-2102 from the Centers for Disease Control and Prevention (CDC) in the third funding year. The funds address childhood lead poisoning prevention and surveillance programmatic activities being conducted from September 30, 2023, to September 29, 2024.

The strategies focus on:

  • Ensuring blood lead testing and reporting
  • Enhancing blood lead surveillance
  • Improving linkages to recommended services

To learn more about these efforts in Wyoming, contact the program below.

Wyoming Childhood Blood Lead Prevention Program

122 West 25th Street

Third Floor West

Cheyenne, WY 82002

Phone: 307-777-7656


Success stories for this funding cycle, September 30, 2021–September 29, 2026, are below.

Success story: funding year 2

Increasing awareness for childhood blood lead testing and reporting requirements in Wyoming


Prior to receiving CDC funding for childhood lead poisoning prevention activities in September 2021, the Wyoming Department of Health (WDH) had limited capacity to conduct outreach and educational activities to community partners. In September 2022, WDH discovered that an organization that conducts blood lead testing statewide on children <6 years of age who are enrolled in Medicaid was unaware of state reporting requirements and CDC's current blood lead reference value (BLRV) of 3.5 μg/dL. Additionally, their regional agencies were unaware of the updated BLRV, and some were unaware that they needed to report blood lead test results to WDH. Lack of reporting resulted in WDH's inability to conduct follow-up and ensure appropriate case-management for children enrolled in Medicaid who have a higher risk of lead exposure.


The childhood blood lead program manager contacted the organization to inform them of the updated BLRV and reporting requirements. The organization invited the program manager to present at an upcoming organization-wide meeting attended by nurses and agency leaders. Topics included sources of lead, effects of lead exposure, methods of prevention, and state reporting methods/requirements. The presentation took place in September 2022 and was distributed to the audience afterwards.


This intervention led to improved surveillance as 145 previous unreported blood lead test results were sent to WDH from 2019 through 2022. Additionally, six patients that tested between 3.5–5 µg/dL who were previously labeled below the BLRV were now accurately categorized as above the BLRV and recommended for referral. This collaboration provides WDH with a more complete data set to accurately make predictions for future testing estimates and testing plans, and it allows WDH to conduct follow-up with families exposed to lead to ensure access to resources and appropriate case management.

Funding for this work was made possible in part by Grant Award# 6 NUE2EH001414-01-03 from the Centers for Disease Control and Prevention (CDC). The views expressed in this material do not necessarily reflect the official policies of the CDC; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.